You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 藥明生物一度漲超3%,公司提議拆細股份以增加交易流動性
uSMART友信智投 09-21 11:29

uSMART友信智投9月21日消息,週一港股,藥明生物一度漲幅高達3.6%,報197.9港元。

今日港股盤前,藥明生物發佈《建議股份拆細》公告,建議將1股拆細爲3

股東特別大會上將予提呈批準股份拆細及其所有相關事宜的普通決議案。

股份拆細的生效日期目前預期爲2020年11月16日(星期一),即緊隨股東特別大會日期後的第二個營業日。

拆細生效後,每手買賣單位將仍爲500股拆細股份。

每手買賣單位不變

股份目前在聯交所買賣,每手買賣單位爲500股現有股份。股份拆細一經生效,拆細股份的每手買賣單位將維持500拆細股份。

股份拆細的理由

董事會相信,股份拆細將提升本公司證券交易的流動性並降低每股股份的交易價格,從而吸引更多投資者並擴大股東基礎。根據於本公告日期收市價每股股份191.1港元,(i) 500股現有股份的每手買賣單位市價爲95,550港元;及(ii)假設股份拆細已生效的理論經調整價格每股拆細股份63.70港元,500股拆細股份的每手買賣單位價值爲31,850港元。因此,董事會認爲股份拆細屬公平合理,並符合本公司及其股東的整體利益。

點擊可跳轉閱讀《藥明生物建議股份拆細公告》原文檔PDF。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account